QUANTUM-SI INC (QSI)

Commit To Buy Quantum-Si At $1, Earn 60.9% Annualized Using Options

Quantum-Si’s New Preprint Showcases Advances in Protein Variant Detection using ProteoVue™ Software with Next-Generation Protein Sequencing™

Quantum-Si Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Quantum-Si Expands International Distribution Network

Top movers in Monday's session

Let's have a look at what is happening on the US markets one hour before the close of the markets on Monday. Below you can find the top gainers and losers in today's session.

Curious about what's happening in today's session? Check out the latest stock movements and price changes.

Let's take a look at the stocks that are in motion in today's session.

Quantum-Si Launches Platinum® New Library Prep Kit, Expanding Access to Next-Generation Protein Sequencing™

Quantum-Si Introduces Protein Barcoding Kit for Multiplexed Protein Screening

Quantum-Si Highlights Major Technical Advances, Next-Generation Platform Architecture and New Proteomic Applications at Investor & Analyst Event

Notable Wednesday Option Activity: QSI, IESC, HOOD

Wednesday Sector Leaders: Education & Training Services, Biotechnology Stocks

Avantor to Distribute Quantum-Si’s Next-Generation Protein Sequencing™ Technology

Quantum-Si to Develop Acceleration Platform and Advance Core Technologies in Collaboration with NVIDIA

Quantum-Si Expands Collaboration with SkyWater to Develop New Chip Production Process Critical for Groundbreaking New Proteomics Platform

Quantum-Si and Planet Innovation to Partner on Proteus™

Quantum-Si Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Quantum-Si Honored with Frost & Sullivan’s 2024 Technology Innovation Leadership Award for Next-Generation Protein Sequencing™

Quantum-Si Reports Third Quarter 2024 Financial Results

University of Virginia Researchers Publish New Study on Tropomyosin Proteoforms Showcasing Quantum-Si’s Next-Gen Protein Sequencer™ Platinum®

Quantum-Si to Participate in Upcoming Investment Conferences

Quantum-Si to Host Investor & Analyst Event in New York City on November 20th, 2024

Quantum-Si to Present at the 2024 American Society of Human Genetics Annual Meeting

Quantum-Si to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024

Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Renowned Proteomic Researchers to Present Quantum-Si Data at World HUPO 2024

Northwestern Proteomics Center of Excellence Partners with Quantum-Si for Webinar on Advancing Proteoform Analysis with Top-Down Mass Spectrometry and Single-Molecule Sequencing

Quantum-Si to Host Investor & Analyst Event in New York City on November 20th, 2024

Liberate Bio Integrates Quantum-Si’s Next-Generation Protein Sequencing™ Platform to Enhance Gene Therapy Development

CORRECTING and REPLACING Quantum-Si Announces New Executive Team Members to Accelerate the Evolution of the Company into a Leading Proteomic Tool Provider

Quantum-Si to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

Quantum-Si Reports Second Quarter 2024 Financial Results